Trump Administration Sinks Teeth Into Paring Down Drug Prices, On 5 Key Points
<p>Asst. Prof. Rena Conti discusses competition between drug makers</p>
The generic drug industry has brought huge cost savings. That may be changing.
Asst. Prof. Rena Conti examines market competition for generic drugs
Step right up for your half-price generic EpiPen
Asst. Prof. Rena Conti discusses how drug prices are obscured by rebates and discounts
Pharmaceutical Policy Reform — Balancing Affordability with Incentives for Innovation
In op-ed, Asst. Prof. Rena Conti explains how lawmakers can lower the cost of prescription drugs
Healthcare deals may boost cancer costs, while state laws stymie telehealth
Asst. Prof. Rena Conti explains increasing cost of outpatient cancer treatment and its effect on patients
The Law of Pharma Pricing: What Goes Up Often Stays Up
Analysis by Asst. Prof. Rena Conti finds a large decrease in makers of injectable cancer drugs
Why Are Prescription Drugs So Expensive? Big Pharma Points To The Cost Of Research And Development, Critics Say That's No Excuse
Article cites Prof. Rena Conti, who argues against claim that cost of pharmaceutical drugs is based primarily on cost of drug's development
International Business Times